Novartis India Limited
NOVARTIND.BO - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$37.2B
Close$
$1302.02
13.8% downside
Current Fair Value
13.8% downsideOvervalued by 13.8% based on the discounted cash flow analysis.
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $37.20 Billion |
|---|---|
| Enterprise Value | $42.64 Billion |
| Earnings per Share | $37.74 |
| Beta | 0.32 |
| Outstanding Shares | 24,690,797 |
Return
| Return on Equity | -0.52% |
|---|---|
| Return on Assets | -0.18% |
| Return on Invested Capital | 4.64% |
Valuation & Multiples
| P/E Ratio | -941.75 |
|---|---|
| PEG | 224.15 |
| Price to Sales | 11.1 |
| Price to Book Ratio | 4.84 |
| Enterprise Value to Revenue | 12.68 |
| Enterprise Value to EBIT | 85.95 |
| Enterprise Value to Net Income | -1069 |
| Total Debt to Enterprise | 0.19 |
| Debt to Equity | 1.03 |
Revenue Sources
No data
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
About Novartis India Limited
59 employees
CEO: Vikas Gupta
Novartis India Limited, an affiliate of Novartis AG, operates as a healthcare enterprise primarily within India. The company's diverse portfolio encompasses a range of therapeutic solutions. These include bone and pain management treatme...